(Q45867023)

17 December 2017

title

Acquired haemophilia - a study of ten cases (English)

1 reference

17 December 2017

1 reference

R Saxena

1

1 reference

17 December 2017

D K Mishra

2

1 reference

17 December 2017

R Kashyap

3

1 reference

17 December 2017

V P Choudhry

4

1 reference

17 December 2017

M Mahapatra

5

1 reference

17 December 2017

M Bhargava

6

1 reference

17 December 2017

publication date

1 March 2000

1 reference

17 December 2017

published in

Haemophilia

1 reference

17 December 2017

volume

6

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

78-83

1 reference

17 December 2017

The immunologic character of acquired inhibitors of antihemophilic globulin (factor 8) and the kinetics of their interaction with factor 8.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00372.X

Localization of human factor FVIII inhibitor epitopes to two polypeptide fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00372.X

Acquired haemophilia: experience of two Italian centres with 17 new cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00372.X

Cytotoxic suppression of acquired factor VIII:C inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00372.X

Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00372.X

Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00372.X

Simultaneous occurrence of lupus anticoagulant and factor VIII inhibitors in hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00372.X

Immunochemistry of factor VIII:C inhibitor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00372.X

Activated prothrombin concentrate for patients with factor VIII inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00372.X

The Relevance of Factor VIII Inactivation Characteristics in the Treatment of Patients with Antibodies Directed against Factor VIII

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2000.00372.X

10.1046/J.1365-2516.2000.00372.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017